NCT05979285

Brief Summary

Migraine is a very common condition characterised by frequent severe headaches that are very debilitating. Although the frequency and severity does reduce as patient's age, particularly above the age of 70, in younger and working age people this condition has a significant impact on people's lives. Patients with migraine are typically diagnosed and managed in primary care, but can also be treated by neurologists. Recently, NHS England has published guidance for clinical staff to optimise patient management: reduce admissions to hospital for migraine and improve the setting in which patients are seen. One recommendation is the increased use of headache diaries by patients. These may help patients and doctors to improve migraine diagnosis and its treatment, for example by identifying if there are triggers for getting a migraine attack. With technological advancements, there are now computer/phone applications (Apps) that can be used instead of a paper diary. The Curelator N1 Headache App is one of such migraine specific Apps. In this study, the investigators aim to evaluate if primary care migraine patients are open to using a digital headache diary App, and how compliant users of the App will be. The investigators also aim to assess patient feedback on the use of the N1 Headache App, and if its use aids them in the management of their migraine.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
887

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 15, 2020

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2021

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 20, 2021

Completed
1.6 years until next milestone

First Submitted

Initial submission to the registry

July 14, 2023

Completed
24 days until next milestone

First Posted

Study publicly available on registry

August 7, 2023

Completed
Last Updated

August 7, 2023

Status Verified

July 1, 2023

Enrollment Period

10 months

First QC Date

July 14, 2023

Last Update Submit

July 27, 2023

Conditions

Keywords

migrainepatient diary

Outcome Measures

Primary Outcomes (2)

  • patient interest in N1 Headache App

    percentage of survey responders who indicate they are willing to trial the N1 Headache App

    30 days

  • user compliance for N1 Headache App

    percentage of participants who consent to using the App who comply with daily use in 90 day trial period

    90 days

Secondary Outcomes (3)

  • previous use of digital diary Apps for migraine

    30 days

  • usefulness of N1 Headache App: percentage patients who identify a migraine trigger

    90 days

  • Health Confidence and digital diary App

    90 days

Study Arms (1)

N1-Headache App

EXPERIMENTAL

All participants used the N1-HEadache App, a digital migraine diary that allows identification of triggers/protectors for migraine (as well as monitoring of medication use)

Device: N1-Headache App (by Curelator)

Interventions

Digital application allowing patients to monitor their migraines, and to identify triggers and/or protectors for their migraines.

N1-Headache App

Eligibility Criteria

Age16 Years - 120 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Primary care patients diagnosed with or attending their GP practice ('coded for') migraine in the last 5 years. This may therefore be newly diagnosed patients or patients with long-standing migraine who attended their GP practice about their condition.
  • Patients aged ≥ 16 years
  • Mental capacity to give consent and not using an interpreter for GP consultations (ie competent in English and capacity to complete postal survey)
  • Part 2 only:
  • Completion of complete part 1 survey, including indication that patient still has ongoing migraine issues.
  • Access to email, internet and Apple or Android technology (ie smartphone, tablet or computer)

You may not qualify if:

  • Under the age of 16 years
  • Unable to fully understand the consent process and provide informed consent due to either language barriers or mental capacity
  • The patient has concurrent (medical) conditions that in the opinion of the investigator may compromise their capacity to complete the survey. Examples would be current severe ill health episode.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Research & Development Department

Carlisle, Cumbria, CA1 3SX, United Kingdom

Location

Related Publications (1)

  • Jonker L, Fitzgerald L, Vanderpol J, Fisher S. Digital diary App use for migraine in primary care: Prospective cohort study. Clin Neurol Neurosurg. 2022 May;216:107225. doi: 10.1016/j.clineuro.2022.107225. Epub 2022 Mar 25.

MeSH Terms

Conditions

Migraine Disorders

Condition Hierarchy (Ancestors)

Headache Disorders, PrimaryHeadache DisordersBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Study Officials

  • Stacey J Fisher, MD

    substantive employee

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Model Details: Prospective cohort study
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 14, 2023

First Posted

August 7, 2023

Study Start

October 15, 2020

Primary Completion

July 31, 2021

Study Completion

December 20, 2021

Last Updated

August 7, 2023

Record last verified: 2023-07

Data Sharing

IPD Sharing
Will not share

Locations